PDF herunterladen
Neurology International Open 2017; 01(04): E287-E293
DOI: 10.1055/s-0043-107843
Review
© Georg Thieme Verlag KG Stuttgart · New York

Role of the Gut Microbiota in Ischemic Stroke

Katarzyna Winek
1   Experimentelle Neurologie, Charité – Universitätsmedizin Berlin
2   NeuroCure Clinical Research, Charité – Universitätsmedizin Berlin
3   Centrum für Schlaganfallforschung Berlin, Charité – Universitätsmedizin Berlin
,
Ulrich Dirnagl
1   Experimentelle Neurologie, Charité – Universitätsmedizin Berlin
2   NeuroCure Clinical Research, Charité – Universitätsmedizin Berlin
3   Centrum für Schlaganfallforschung Berlin, Charité – Universitätsmedizin Berlin
4   Klinik für Neurologie, Charité – Universitätsmedizin Berlin
5   Deutsches Zentrum für neurodegenerative Erkrankungen (DZNE), Standort Berlin
6   Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), Standort Berlin
,
Andreas Meisel
1   Experimentelle Neurologie, Charité – Universitätsmedizin Berlin
2   NeuroCure Clinical Research, Charité – Universitätsmedizin Berlin
3   Centrum für Schlaganfallforschung Berlin, Charité – Universitätsmedizin Berlin
4   Klinik für Neurologie, Charité – Universitätsmedizin Berlin
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
17. Oktober 2017 (online)

   Lizenzen und Reprints

Abstract

Recent studies have provided evidence for the role of the gut microbiota in the homeostasis of the central nervous system (CNS) and in the pathophysiology of its disorders, e. g. by regulation of the peripheral immune response. In this article, we discuss the importance of the gut microbiota in stroke by providing a summary of available clinical and experimental data suggesting that 1) stroke changes the gut microbiome, 2) microbiota modulates stroke outcome and 3) microbiota plays an important role in the pathogenesis of stroke (risk factors). Currently available clinical and experimental evidence suggests an important role of gut microbiota in stroke and promises clinically relevant discoveries within coming years.

Key words

microbiota - microbiome - stroke - CNS
 

  • References

  • 1 Qin J, Li R, Raes J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464: 59-65
    CrossrefPubMedGoogle Scholar
  • 2 O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep 2006; 7: 688-693
    CrossrefPubMedGoogle Scholar
  • 3 Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009; 9: 313-323
    CrossrefPubMedGoogle Scholar
  • 4 Braniste V, Al-Asmakh M, Kowal C. et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med 2014; 6: 263ra158 doi: 10.1126/scitranslmed.3009759
    CrossrefPubMedGoogle Scholar
  • 5 Erny D, Hrabe de Angelis AL, Jaitin D. et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 2015; 18: 965-977
    CrossrefPubMedGoogle Scholar
  • 6 Hoban AE, Stilling RM, Ryan FJ. et al. Regulation of prefrontal cortex myelination by the microbiota. Transl Psychiatry 2016; 6: e774
    CrossrefPubMedGoogle Scholar
  • 7 Luczynski P, McVey Neufeld KA, Oriach CS. et al. Growing up in a bubble: using germ-free animals to assess the influence of the gut microbiota on brain and behavior. Int J Neuropsychopharmacol 2016; DOI: 10.1093/ijnp/pyw020.
    PubMedGoogle Scholar
  • 8 De Paepe M, Leclerc M, Tinsley CR. et al. Bacteriophages: an underestimated role in human and animal health?. Front Cell Infect Microbiol 2014; 4: 39
    PubMedGoogle Scholar
  • 9 Ogilvie LA, Jones BV. The human gut virome: a multifaceted majority. Frontiers in microbiology 2015; 6: 918
    PubMedGoogle Scholar
  • 10 Backhed F, Ley RE, Sonnenburg JL. et al. Host-bacterial mutualism in the human intestine. Science 2005; 307: 1915-1920
    CrossrefPubMedGoogle Scholar
  • 11 Nguyen TL, Vieira-Silva S, Liston A. et al. How informative is the mouse for human gut microbiota research?. Dis Model Mech 2015; 8: 1-16
    CrossrefPubMedGoogle Scholar
  • 12 Houlden A, Goldrick M, Brough D. et al. Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production. Brain Behav Immun 2016; DOI: 10.1016/j.bbi.2016.04.003.
    PubMedGoogle Scholar
  • 13 Singh V, Roth S, Llovera G. et al. Microbiota dysbiosis controls the neuroinflammatory response after stroke. J Neurosci 2016; 36: 7428-7440
    CrossrefPubMedGoogle Scholar
  • 14 Swidsinski AL-B V, Krüger M, Kirsch S. Central nervous system and the colonic bioreactor: analysis of colonic microbiota in patients with stroke unravels unknown mechanisms of the host defense after brain injury. Intest Res 2012; 10: 332-342
    CrossrefPubMedGoogle Scholar
  • 15 Karlsson FH, Fak F, Nookaew I. et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun 2012; 3: 1245 doi: 10.1038/ncomms2266
    CrossrefPubMedGoogle Scholar
  • 16 Koren O, Spor A, Felin J. et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci USA 2010; 108 (Suppl. 01) 4592-4598
    PubMedGoogle Scholar
  • 17 Yin J, Liao SX, He Y et al. Dysbiosis of gut microbiota with reduced trimethylamine-N-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack. J Am Heart Assoc 2015; 4: doi: 10.1161/JAHA.115.002699
    PubMed
  • 18 Mayer EA, Tillisch K, Gupta A. Gut/brain axis and the microbiota. J Clin Invest 2015; 125: 926-938
    CrossrefPubMedGoogle Scholar
  • 19 Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 2009; 136: 2003-2014
    CrossrefPubMedGoogle Scholar
  • 20 Schulte-Herbruggen O, Quarcoo D, Meisel A. et al. Differential affection of intestinal immune cell populations after cerebral ischemia in mice. Neuroimmunomodulation 2009; 16: 213-219
    CrossrefPubMedGoogle Scholar
  • 21 Caso JR, Hurtado O, Pereira MP. et al. Colonic bacterial translocation as a possible factor in stress-worsening experimental stroke outcome. Am J Physiol Regul Integr Comp Physiol 2009; 296: R979-R985
    CrossrefPubMedGoogle Scholar
  • 22 Tascilar N, Irkorucu O, Tascilar O. et al. Bacterial translocation in experimental stroke: what happens to the gut barrier?. Bratisl Lek Listy 2010; 111: 194-199
    PubMedGoogle Scholar
  • 23 Crapser J, Ritzel R, Verma R. et al. Ischemic stroke induces gut permeability and enhances bacterial translocation leading to sepsis in aged mice. Aging (Albany NY) 2016; 8: 1049-1063
    PubMedGoogle Scholar
  • 24 Jandzinski M. Manipulation of the microbiome and its impact on functional recovery following ischemic stroke. Honors Scholar Theses Paper 414 2015; http://digitalcommons.uconn.edu/srhonors_theses/414
    PubMedGoogle Scholar
  • 25 Stanley D, Mason LJ, Mackin KE. et al. Translocation and dissemination of commensal bacteria in post-stroke infection. Nat Med 2016; 22: 1277-1284
    CrossrefPubMedGoogle Scholar
  • 26 Hannawi Y, Hannawi B, Rao CP. et al. Stroke-associated pneumonia: major advances and obstacles. Cerebrovasc Dis 2013; 35: 430-443
    CrossrefPubMedGoogle Scholar
  • 27 Meisel C, Schwab JM, Prass K. et al. Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci 2005; 6: 775-786
    CrossrefPubMedGoogle Scholar
  • 28 Prass K, Braun JS, Dirnagl U. et al. Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke 2006; 37: 2607-2612
    CrossrefPubMedGoogle Scholar
  • 29 Benakis C, Brea D, Caballero S. et al. Commensal microbiota affects ischemic stroke outcome by regulating intestinal gammadelta T cells. Nat Med 2016; 22: 516-523
    CrossrefPubMedGoogle Scholar
  • 30 Prass K, Meisel C, Hoflich C. et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 2003; 198: 725-736
    CrossrefPubMedGoogle Scholar
  • 31 Dirnagl U, Klehmet J, Braun JS. et al. Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke 2007; 38: 770-773
    CrossrefPubMedGoogle Scholar
  • 32 Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med 2011; 17: 796-808
    CrossrefPubMedGoogle Scholar
  • 33 Chamorro A, Meisel A, Planas AM. et al. The immunology of acute stroke. Nat Rev Neurol 2012; 8: 401-410
    CrossrefPubMedGoogle Scholar
  • 34 Liesz A, Hu X, Kleinschnitz C. et al. Functional role of regulatory lymphocytes in stroke: facts and controversies. Stroke 2015; 46: 1422-1430
    CrossrefPubMedGoogle Scholar
  • 35 Chow J, Mazmanian SK. Getting the bugs out of the immune system: do bacterial microbiota "fix" intestinal T cell responses?. Cell Host Microbe 2009; 5: 8-12
    CrossrefPubMedGoogle Scholar
  • 36 Sun J, Wang F, Ling Z. et al. Clostridium butyricum attenuates cerebral ischemia/reperfusion injury in diabetic mice via modulation of gut microbiota. Brain Res 2016; 1642: 180-188
    CrossrefPubMedGoogle Scholar
  • 37 Winek K, Engel O, Koduah P. et al. Depletion of cultivatable gut microbiota by broad-spectrum antibiotic pretreatment worsens outcome after murine stroke. Stroke 2016; 47: 1354-1363
    CrossrefPubMedGoogle Scholar
  • 38 Nakasone C, Yamamoto N, Nakamatsu M. et al. Accumulation of gamma/delta T cells in the lungs and their roles in neutrophil-mediated host defense against pneumococcal infection. Microbes Infect 2007; 9: 251-258
    CrossrefPubMedGoogle Scholar
  • 39 Marsland BJ, Trompette A, Gollwitzer ES. The gut-lung axis in respiratory disease. Ann Am Thorac Soc 2015; 12 (Suppl. 02) S150-S156
    PubMedGoogle Scholar
  • 40 Schuijt TJ, Lankelma JM, Scicluna BP. et al. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut 2016; 65: 575-583
    CrossrefPubMedGoogle Scholar
  • 41 Rosenfeld ME, Campbell LA. Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis. Thromb Haemost 2011; 106: 858-867
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 42 Wang Z, Klipfell E, Bennett BJ. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011; 472: 57-63
    CrossrefPubMedGoogle Scholar
  • 43 Zhu W, Gregory JC, Org E. et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis Risk. Cell 2016; 165: 111-124
    CrossrefPubMedGoogle Scholar
  • 44 Koeth RA, Wang Z, Levison BS. et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013; 19: 576-585
    CrossrefPubMedGoogle Scholar
  • 45 Tang WH, Wang Z, Levison BS. et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 2013; 368: 1575-1584
    CrossrefPubMedGoogle Scholar
  • 46 Stepankova R, Tonar Z, Bartova J. et al. Absence of microbiota (germ-free conditions) accelerates the atherosclerosis in ApoE-deficient mice fed standard low cholesterol diet. J Atheroscler Thromb 2010; 17: 796-804
    CrossrefPubMedGoogle Scholar
  • 47 Singh V, Yeoh BS, Vijay-Kumar M. Gut microbiome as a novel cardiovascular therapeutic target. Curr Opin Pharmacol 2016; 27: 8-12
    CrossrefPubMedGoogle Scholar
  • 48 Troseid M, Ueland T, Hov JR. et al. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure. J Intern Med 2015; 277: 717-726
    CrossrefPubMedGoogle Scholar
  • 49 Troseid M, Hov JR, Nestvold TK. et al. Major increase in microbiota-dependent proatherogenic metabolite TMAO one year after bariatric surgery. Metab Syndr Relat Disord 2016; 14: 197-201
    CrossrefPubMedGoogle Scholar
  • 50 Sacco RL, Benjamin EJ, Broderick JP. et al. American heart association prevention conference. IV. Prevention and rehabilitation of stroke. risk factors. Stroke 1997; 28: 1507-1517
    CrossrefPubMedGoogle Scholar
  • 51 Winek K, Dirnagl U, Meisel A. The gut microbiome as therapeutic target in central nervous system diseases: implications for stroke. Neurotherapeutics 2016; 13: 762-774
    CrossrefPubMedGoogle Scholar
  • 52 Winek K, Meisel A, Dirnagl U. Gut microbiota impact on stroke outcome: Fad or fact?. J Cereb Blood Flow Metab 2016; 36: 891-898
    CrossrefPubMedGoogle Scholar
  • 53 Schaller BJ, Graf R, Jacobs AH. Pathophysiological changes of the gastrointestinal tract in ischemic stroke. Am J Gastroenterol 2006; 101: 1655-1665
    CrossrefPubMedGoogle Scholar
  • 54 Tottey W, Feria-Gervasio D, Gaci N. et al. Colonic transit time is a driven force of the gut microbiota composition and metabolism: in vitro evidence. J Neurogastroenterol Motil 2017; 23: 124-134
    CrossrefPubMedGoogle Scholar
  • 55 Jernberg C, Lofmark S, Edlund C. et al. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 2007; 1: 56-66
    CrossrefPubMedGoogle Scholar
  • 56 Ravel J, Wommack KE. All hail reproducibility in microbiome research. 2014; DOI: D - NLM: PMC3975297 EDAT- 2014/03/08 06:00 MHDA- 2014/03/08 06:01 CRDT- 2014/03/08 06:00 PHST- 2014/03/03 [received] PHST- 2014/03/03 [accepted] AID - 2049-2618-2-8 [pii] AID - 10.1186/2049-2618-2-8 [doi] PST - epublish
    PubMed
  • 57 Servick K. Mouse microbes may make scientific studies harder to replicate. Science 2016; DOI: 10.1126/science.aah7199.
    PubMedGoogle Scholar
  • 58 Bleich A, Hansen AK. Time to include the gut microbiota in the hygienic standardisation of laboratory rodents. Comp Immunol Microbiol Infect Dis 2012; 35: 81-92
    CrossrefPubMedGoogle Scholar
  • 59 Sadler R, Singh V, Benakis C. et al. Microbiota differences between commercial breeders impacts the post-stroke immune response. Brain Behav Immun 2017; DOI: 10.1016/j.bbi.2017.03.011.
    PubMedGoogle Scholar
  • 60 Sivan A, Corrales L, Hubert N. et al. Commensal bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 2015; 350: 1084-1089
    CrossrefPubMedGoogle Scholar
  • 61 Vetizou M, Pitt JM, Daillere R. et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 2015; 350: 1079-1084
    CrossrefPubMedGoogle Scholar
  • 62 Ferguson JF, Allayee H, Gerszten RE. et al. Nutrigenomics, the microbiome, and gene-environment interactions: new directions in cardiovascular disease research, prevention, and treatment: a scientific statement from the american heart association. Circ Cardiovasc Genet 2016; 9: 291-313
    CrossrefPubMedGoogle Scholar